166 related articles for article (PubMed ID: 35310729)
1. Endoscopic and histopathologic features of Anti-PD-1-related collagenous colitis.
Kikuchi H; Sakuraba H; Akemoto Y; Hosoi K; Murai Y; Hoshi K; Fukutoku Y; Asari T; Sawada Y; Hasui K; Tatsuta T; Hiraga H; Chinda D; Mikami T; Fukuda S
DEN Open; 2022 Apr; 2(1):e92. PubMed ID: 35310729
[TBL] [Abstract][Full Text] [Related]
2. A case of immune checkpoint inhibitor-related colitis with a distinctive endoscopic finding of colonic pseudolipomatosis.
Naito T; Nosaka T; Takahashi K; Ofuji K; Matsuda H; Ohtani M; Hiramatsu K; Imamura Y; Ishizuka T; Nakamoto Y
Clin J Gastroenterol; 2021 Oct; 14(5):1431-1436. PubMed ID: 34106395
[TBL] [Abstract][Full Text] [Related]
3. Collagenous colitis and atezolizumab therapy: an atypical case.
Gallo A; Talerico R; Novello L; Giustiniani MC; D'Argento E; Bria E; Montalto M
Clin J Gastroenterol; 2021 Feb; 14(1):165-169. PubMed ID: 33151423
[TBL] [Abstract][Full Text] [Related]
4. Immune-related adverse events in the gastrointestinal tract: diagnostic utility of upper gastrointestinal biopsies.
Zhang ML; Neyaz A; Patil D; Chen J; Dougan M; Deshpande V
Histopathology; 2020 Jan; 76(2):233-243. PubMed ID: 31361907
[TBL] [Abstract][Full Text] [Related]
5. Immune checkpoint inhibitor-related colitis in patients on immunotherapy for cancer.
Sun BL; Elliott AS; Nolte D; Sun X
Am J Clin Pathol; 2024 Jul; 162(1):17-27. PubMed ID: 38377034
[TBL] [Abstract][Full Text] [Related]
6. Magnifying endoscopy with crystal violet staining for immune checkpoint inhibitor-associated colitis.
Inoue S; Kono M; Fukuda H; Shimamoto Y; Nakagawa K; Ohmori M; Iwagami H; Matsuno K; Iwatsubo T; Nakahira H; Matsuura N; Shichijo S; Maekawa A; Kanesaka T; Yamamoto S; Takeuchi Y; Higashino K; Uedo N; Kitamura M; Nakatsuka S; Kunimasa K; Kumagai T; Isei T; Ishihara R
J Gastroenterol Hepatol; 2021 May; 36(5):1180-1186. PubMed ID: 32888202
[TBL] [Abstract][Full Text] [Related]
7. Colon Immune-Related Adverse Events: Anti-CTLA-4 and Anti-PD-1 Blockade Induce Distinct Immunopathological Entities.
Coutzac C; Adam J; Soularue E; Collins M; Racine A; Mussini C; Boselli L; Kamsukom N; Mateus C; Charrier M; Cassard L; Planchard D; Ribrag V; Fizazi K; Loriot Y; Lepage P; Scoazec JY; Robert C; Carbonnel F; Chaput N
J Crohns Colitis; 2017 Oct; 11(10):1238-1246. PubMed ID: 28967957
[TBL] [Abstract][Full Text] [Related]
8. Colitis nucleomigrans: The third type of microscopic colitis (part 1).
Tachibana M; Hanaoka T; Watanabe S; Matsushita M; Isono T; Tsutsumi Y
Pathol Int; 2020 Oct; 70(10):752-760. PubMed ID: 32761850
[TBL] [Abstract][Full Text] [Related]
9. Different distribution of mast cells and macrophages in colonic mucosa of patients with collagenous colitis and inflammatory bowel disease.
Nishida Y; Murase K; Isomoto H; Furusu H; Mizuta Y; Riddell RH; Kohno S
Hepatogastroenterology; 2002; 49(45):678-82. PubMed ID: 12063968
[TBL] [Abstract][Full Text] [Related]
10. Endoscopic and Histologic Features of Immune Checkpoint Inhibitor-Related Colitis.
Wang Y; Abu-Sbeih H; Mao E; Ali N; Qiao W; Trinh VA; Zobniw C; Johnson DH; Samdani R; Lum P; Shuttlesworth G; Blechacz B; Bresalier R; Miller E; Thirumurthi S; Richards D; Raju G; Stroehlein J; Diab A
Inflamm Bowel Dis; 2018 Jul; 24(8):1695-1705. PubMed ID: 29718308
[TBL] [Abstract][Full Text] [Related]
11. Immune checkpoint inhibitor colitis: the flip side of the wonder drugs.
Assarzadegan N; Montgomery E; Anders RA
Virchows Arch; 2018 Jan; 472(1):125-133. PubMed ID: 29143108
[TBL] [Abstract][Full Text] [Related]
12. Multi-detector computed tomography (MDCT)-based severity score as a prognostic tool in patients with suspected immune checkpoint inhibitor therapy associated colitis.
Pisuchpen N; Durbin SM; Mooradian MJ; Fintelmann FJ; Reynolds KL; Dougan M; Kambadakone A
Eur Radiol; 2021 Dec; 31(12):8868-8878. PubMed ID: 34081152
[TBL] [Abstract][Full Text] [Related]
13. Immune checkpoint inhibitor-associated celiac disease.
Badran YR; Shih A; Leet D; Mooradian MJ; Coromilas A; Chen J; Kem M; Zheng H; Borowsky J; Misdraji J; Mino-Kenudson M; Dougan M
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32581063
[TBL] [Abstract][Full Text] [Related]
14. Endoscopic and histopathological evaluation of collagenous colitis.
Narabayashi K; Murano M; Egashira Y; Noda S; Kawakami K; Ishida K; Kuramoto T; Abe Y; Inoue T; Murano N; Tokioka S; Takii M; Umegaki E; Higuchi K
Digestion; 2012; 85(2):136-40. PubMed ID: 22269295
[TBL] [Abstract][Full Text] [Related]
15. Collagenous colitis: histopathology and clinical course.
Goff JS; Barnett JL; Pelke T; Appelman HD
Am J Gastroenterol; 1997 Jan; 92(1):57-60. PubMed ID: 8995938
[TBL] [Abstract][Full Text] [Related]
16. Activation of nuclear factor kappaB in colonic mucosa from patients with collagenous and ulcerative colitis.
Andresen L; Jørgensen VL; Perner A; Hansen A; Eugen-Olsen J; Rask-Madsen J
Gut; 2005 Apr; 54(4):503-9. PubMed ID: 15753535
[TBL] [Abstract][Full Text] [Related]
17. Programmed cell death-1 (PD-1) and programmed death-ligand 1 (PD-L1) expression in PD-1 inhibitor-associated colitis and its mimics.
Cassol CA; Owen D; Kendra K; Braga JR; Frankel WL; Arnold CA
Histopathology; 2020 Aug; 77(2):240-249. PubMed ID: 32298485
[TBL] [Abstract][Full Text] [Related]
18. Linear mucosal defect may be characteristic of lansoprazole-associated collagenous colitis.
Umeno J; Matsumoto T; Nakamura S; Jo Y; Yada S; Hirakawa K; Yoshimura R; Yamagata H; Kudo T; Hirano A; Gushima M; Yao T; Nakashima Y; Iida M
Gastrointest Endosc; 2008 Jun; 67(7):1185-91. PubMed ID: 18513560
[TBL] [Abstract][Full Text] [Related]
19. Collagenous colitis and lymphocytic colitis: clinical and endoscopic findings.
De La Riva S; Betés MT; Duque JM; Angós R; Muñoz Navas MA
Rev Esp Enferm Dig; 2000 Feb; 92(2):86-96. PubMed ID: 10757866
[TBL] [Abstract][Full Text] [Related]
20. Are collagenous colitis and lymphocytic colitis distinct syndromes?
Jackson BK
Dig Dis; 1995; 13(5):301-11. PubMed ID: 8542665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
